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Materials and Methods 
Magnetite nanoparticles in the size range of 3.2-
7.5 nm were synthesized with high yields under 
variable reaction conditions using high 
temperature hydrolysis of the precursor iron(II) 
and iron(III) chelated alkoxide complexes in 
surfactant-free diethylene glycol solutions.  The 
average sizes of the particles were adjusted by 
changing the reaction temperature and time, and 
by using sequential growth technique. Reaction 
products formed as shelf-stable colloids. In order 
to obtain γ-iron(III) oxide particles in the same 
range of sizes, diethylene glycol colloids of 
magnetite were oxygenated at room temperature. 
As-obtained colloids were characterized by DLS; 
powdery products obtained by coagulating them 
with oleic acid, were characterized by TEM, XRD, 
TGA, FTIR and magnetic measurements.   
Sample Magnetization, emu/g r1(OH) r1(CH2) 
15 kOe 50kOe 
Fe3O4 3.2 nm 30 49 0.65 0.29 
Fe3O4 4.8 nm 52 58 2.72 1.04 
Fe3O4 7.5 nm 66 70 4.74 2.24 
Fe2O3 3.2 nm -  - 0.68 0.39 
Fe2O3 4.8 nm 41 46 2.84 1.22 
Fe2O3 7.5 nm -  - 5.97 2.16 
Sample r1 r2 r2/r1 
GdDTPA 4.81 3.84 0.80 
Fe2O3 3.2 nm 3.00 23.75 7.92 
Fe2O3 4.8 nm 3.52 28.26 8.03 
Fe2O3 7.5 nm 10.8 204.2 18.91 
The Results 
The notable finding about magnetic properties 
of the synthesized nanoparticles was that 
γ-iron(III) oxide particles had ~ 20 % lower 
saturation magnetization than the magnetite 
particles of the same size. The NMR relaxivity 
studies revealed similar longitudinal (r1) 
relaxivity values for magnetite and γ-iron(III) 
oxide and have shown that there is a linear 
relationship between r1 values and particle 
size for both types of particles with the slope 
greater for OH-protons. The r2 values are 
more strongly affected by the particle size 
than the r1 values, and consequently, the r2/r1 
ratios decrease with the particle size 
reduction. This makes smaller particles 
suitable candidates for positive contrast 
enhancing MRI agents.  Based on magnetic 
and relaxivity properties, the γ-iron(III) oxide 
particles would be even better candidates for 
this role than the magnetite particles, as they 
are chemically more stable and consequently 
less toxic. 
Magnetization and relaxivity data in diethylene glycol 
Relaxivity of γ-iron(III) oxide nanoparticles  
and magnevist in deuterium oxide 
Application of superparamagnetic iron oxide 
nanoparticles in biology and medicine finds its 
rapidly developing emphasis on contrast agents 
for MRI.  Positive contrast imaging is frequently 
preferred in diagnostic practice, however the 
existing gadolinium-containing T1 contrast agents 
raise substantial toxicity issues, and their high 
mobility shortens their presence in the vascular 
system.  These drawbacks of gadolinium contrast 
agents motivate the researchers’ effort on 
development of T1 contrast agents based on 
ultrasmall superparamagnetic iron oxide particles.   
Due to their high magnetic moment, 
superparamagnetic nanoparticles enhance proton 
relaxation predominantly via outer-sphere 
mechanism and therefore act as negative (T2) 
contrast agents.  In positive (T1) contrast agents, 
the inner-sphere relaxation mechanism is utilized 
due to interaction of protons with the high-spin d5 
transition metal ions such as MnII and FeIII, or 
more commonly, the f7 GdIII ions.   
The best currently known blood pool MRI agents 
are based on iron oxides and considered non-
toxic.  Reducing the particle size below 5 nm can 
lower their magnetic moment, and therefore the 
outer-sphere relaxivity r2.  At the same time larger 
surface-to-volume ratio of these small particles 
can cause greater involvement of iron atoms in the 
spin-lattice relaxation process, which relies on 
direct water coordination and exchange at the 
metal sites.   Consequently, particle size reduction 
can be the way to obtaining a better T1 contrast 
agent. One of the goals of this work was to study 
how particle size affects the magnetic and 
relaxivity properties.  We intentionally used no 
capping ligands or surfactants to make sure they 
would not interfere with water coordination and 
exchange at the particle’s surface, which is 
important for accurate T1 measurements. 
It is known that magnetite spontaneously oxidizes 
in the air yielding γ-iron(III) oxide with similar 
crystal structure.  Similarity of their structures 
reflects on the magnetic properties being alike: 
maghemite (γ-Fe2O3) has saturation magnetization 
value ~80% of the value for magnetite.  It could be 
expected that particles with the same size but 
different oxidation state of iron, would show similar 
r2 relaxivity due to similarity of their magnetic 
moments.  They might show very different r1 
relaxivities, however, due to their different surface 
chemistry and physics.  Study on how iron 
oxidation state affects the magnetic and relaxivity 
properties of the nanoparticles, was another goal 
of this work.   
Typical experiment in determining the relaxivity by measuring the 
relaxation time for signals of the solvent at a presence of variable amounts 
of  magnetic material. 
 
 I = Io(1 - 2e(t/T1))     1/T = 1/T0 + r[Fe] 
I – signal intensity     T0 – relaxation time for pure solvent ([Fe] = 0)  
t – time        Slope determines the relaxivity r 
